Spring direct naar de hoofdnavigatie of de inhoud
‘An adequate IP strategy protects innovation and creates new chances’
Home / Experts / Marthe Lindenbergh
Marthe Lindenbergh

Marthe Lindenbergh

  • Life Sciences
  • Dutch Patent Attorney
  • Associate
T +31 30 785 63 74

Marthe Lindenbergh obtained a Bachelor’s and Master’s degree in Biomedical Sciences at Utrecht University. During the Master-phase, she did research internships in the UMC Utrecht and at the University of California, San Francisco. Having specialized in Infection and Immunity, she continued her studies with a PhD track at Utrecht University and the Wilhelmina Children’s Hospital, where she studied the immune-modulatory functions of immune-cell-derived extracellular vesicles. In 2019 she started at V.O. She obtained her PhD in November 2019.

Continue reading

Working experience

  • Patent Attorney, V.O. (September 2022)
  • Trainee Patent Attorney, V.O. (2019-present)
  • PhD University of Utrecht (2014-2018)

Education

  • PhD Infection and Immunity, University of Utrecht (2019)
  • MSc Infection and Immunity, University ofUtrecht (2014)
  • BSc Biomedical Sciences , University of Utrecht (2012)

Publications

  • M. Mues, L. Karra, D. Romero-Moya, A. Wandler, M. J. Hangauer, O. Ksionda, Y. Thus, M.F.S. Lindenbergh, K. Shannon, M. T. McManus, J. P. Roose. “High-complexity shRNA libraries and PI3 kinase inhibition in cancer: high-fidelity synthetic lethality predictions”. Cell Reports 2019
  • M.F.S. Lindenbergh, D.G.J. Koerhuis, E.G.F. Borg, E.M. van ’t Veld, T.A.P. Driedonks, R. Wubbolts, W. Stoorvogel, M. Boes. “Bystander T-cells support clonal T-cell activation by controlling the release of dendritic cell-derived immune-stimulatory extracellular vesicles”. Front. Imm. 2019
  • M.F.S. Lindenbergh, W. Stoorvogel. “Antigen presentation by extracellular vesicles from professional antigen-presenting cells”.  Annu. Rev. Immunol. 2018
  • A.M. Gram, T. Oosenbrug, M.F.S. Lindenbergh, C. Büll, A. Comvalius, K.J.I. Dickson, J. Wiegant, H. Vrolijk, R.J. Lebbink, R. Wolterbeek, G.J. Adema, M. Griffioen, M.H.M. Heemskerk, D.C. Tscharke, L. M. Hutt-Fletcher, E.J.H.J. Wiertz, R.C. Hoeben, M.E. Ressing. “The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells”. PLoS Path. 2016
  • M. van Gent, A.M. Gram, I.G.J. Boer, R.J. Geerdink, M.F.S. Lindenbergh, R.J. Lebbink, E.J. Wiertz, M.E. Ressing. “Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion”.  J. Gen. Virol. 2015.

Languages

  • Dutch
  • English

See also

Also see these experts

Marijke Westra

Marijke Westra

  • European and Dutch Patent Attorney
  • Senior Associate
+31 70 416 68 14
Saskia van Doorn

Saskia van Doorn

  • European and Dutch Patent Attorney
  • Senior Associate
+31 30 785 63 61
More experts

News

Three new partners at V.O.

As of 1 January 2023, three new partners have joined V.O., namely patent attorneys Jetze Beeksma, Henri van Kalkeren and Martin Klok.Continue reading

Participation in iGEM competition with cup that detects GHB

The annual IGEM (International Genetically Engineered Machine) competition allows students to tackle societal problems through synthetic biology.Continue reading

Montenegro acceded as an EPC member state

Since 1 October 2022, Montenegro has been a full EPC member state. Before that, Montenegro had the status of an enlargement country.Continue reading

More news

Events

Beta Business Days 2023

Martiniplaza, Leonard Springerlaan, Groningen

De Beta Business Days is een tweedaags evenement met als doel contacten te leggen tussen bedrijven en ambitieuze studenten uit Groningen.

Continue reading

Jobfair Forum Enterprises Liège 2023

Allée de la Découverte 9, Liège, Belgium

Forum Entreprises is an exclusive way to allow dialogue and interactions between, in particular, master students of engineering and applied science, and their future employers.

Continue reading

More events